These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 8430938)
1. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
2. Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies. Wilson DV; Stick JA Am J Vet Res; 1993 Mar; 54(3):443-8. PubMed ID: 8498751 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913 [TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560 [TBL] [Abstract][Full Text] [Related]
6. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers. Adamus WS; Heuer H; Meade CJ Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related]
8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
9. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats. Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165 [TBL] [Abstract][Full Text] [Related]
10. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats. Qi M; Jones SB Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318 [TBL] [Abstract][Full Text] [Related]
11. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis. Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923 [TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity. Bouvier C; Guc MO; Furman BL; Parratt JR Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505 [TBL] [Abstract][Full Text] [Related]
13. Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086. van der Zee H; Moon DG; Kaplan JE; Gudewicz PW; Fenton J J Lab Clin Med; 1991 Apr; 117(4):305-12. PubMed ID: 1901342 [TBL] [Abstract][Full Text] [Related]
14. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats. Bocheński J; Chłopicki S; Gryglewski RJ J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723 [TBL] [Abstract][Full Text] [Related]
15. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Foster AP; Lees P; Andrews MJ; Cunningham FM Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis. Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility. Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979 [TBL] [Abstract][Full Text] [Related]
18. Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit. Lohman I; Halonen M Am Rev Respir Dis; 1990 Aug; 142(2):390-7. PubMed ID: 2382903 [TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry. Rocha FA; Jancar S; Fraga CA; Timo-Iaria C; De Brum-Fernandes AJ J Rheumatol; 1993 Aug; 20(8):1374-7. PubMed ID: 8230022 [TBL] [Abstract][Full Text] [Related]